Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Adjunctive Treatment for Schizophrenia
Clinical trial NCT05654870 · TERMINATED
Trial details
- NCT number
- NCT05654870
- Sponsor
- Neurocrine Biosciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-05
- Primary completion
- 2023-11-08
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.